Trinity Biotech Invests in Novus Diagnostics to Accelerate Rapid Sepsis Testing
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MorePosted by Andy Lundin | Nov 27, 2024 | Company News, Sepsis |
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MorePosted by Andy Lundin | Nov 15, 2024 | Kidney Disease, Urine Analyzers |
Healthy.io’s kidney test demonstrated 96.4% sensitivity in detecting albuminuria, showcasing its potential to improve early detection of CKD.
Read MorePosted by Chris Wolski | Nov 13, 2024 | Diagnostic Technologies |
For the second year in a row, industry experts predict automation and AI as top clinical laboratory trends in 2025.
Read MorePosted by Andy Lundin | Oct 25, 2024 | Diagnostic Technologies |
A novel optical technique using Orbital Angular Momentum (OAM) light could revolutionize non-invasive diagnostics.
Read MorePosted by Andy Lundin | Oct 23, 2024 | Molecular Diagnostics, Urinalysis & Toxicology |
Researchers are exploring urine analysis as a tool for early detection of diseases by studying RNA and other substances in urine.
Read More